依托"AI京医"的升级，京东互联网医院的服务效率和体验均有显著提升。一方面，通过专家医生智能体与AI诊疗助手的协同，医生的接 诊响应速度进一步优化；另一方面，借助京东健康"医、检、诊、药"闭环服务，用户与AI的互动不仅仅是简单的咨询问答，更重要的是 满足后链路需求，比如可以直接在线完成医药健康产品购买、检查预约等服务，真正享受到"一站式体验"。截至2025年6月30日，"AI京 医"智能体累计服务用户数已超5000万，覆盖看病买药的线上全流程、全场景。 此外，京东健康还发布了业内首个医院全场景应用AI产品——京东卓医(JOY DOC)，通过构建"个人就医管家""医生数字分身"和"未来数 字医院"，致力于让患者看病更舒心、医生临床科研更高效、医院整体运营更轻松。目前，"京东卓医"已在多家医疗机构落地。其中，京 东健康与温州医科大学附属第一医院合作打造的、基于AI驱动的门诊患者服务流程闭环，已累计服务患者超220万人次。 未来，京东健康将进一步推动AI应用的更大规模落地，以人工智能技术驱动服务模式创新，致力于让医疗健康服务变得更智能、更普 惠。 上半年，京东健康发布了应用于线上全场景的"AI京医"系列产品，包括面 ...

北京商报讯（记者 王寅浩 实习记者 宋雨盈）8月14日，京东健康发布公告称，2025年上半年实现营业 收入352.9亿元，同比增长24.5%；归属于公司所有者的期间盈利25.96亿元，同比增加27.45%。 ...

Core Insights - JD Health reported a total revenue of 35.3 billion yuan for the first half of 2025, representing a year-on-year growth of 24.5% [1] - The Non-IFRS net profit reached 3.57 billion yuan, showing a year-on-year increase of 35% [1] - The number of annual active users on JD Health's platform exceeded 200 million as of June 30, 2025 [1] Revenue and User Growth - JD Health's revenue growth is attributed to the enhancement of its self-operated, online platform, and instant retail channels [1] - The platform has over 150,000 merchants as of June 30, 2025 [1] Service Expansion and Innovations - JD Health's instant retail business has linked over 200,000 pharmacies nationwide, expanding online medical insurance payment services to nearly 200 million people [1] - The company is exploring innovative service models for retail pharmacies, including a collaboration with Beijing Children's Hospital to establish a pediatric pharmacy model [1] Healthcare Service Integration - JD Health has developed a comprehensive service loop covering "medical, testing, diagnosis, and medication" through its internet hospital [2] - The average daily consultation volume for JD Internet Hospital exceeded 500,000 as of June 30, 2025 [2] Home Healthcare Services - The home nursing service has expanded to cover 64 service items across 7 categories, including home care and traditional Chinese medicine care [2] - JD Health has also expanded its rapid testing service network, offering over 160 rapid testing services to users in 23 cities [2] AI Integration in Healthcare - JD Health launched the AI Jingyi series products for online scenarios, including AI doctors, pharmacists, nutritionists, and psychological consultants [2] - The AI Jingyi intelligent agents have served over 50 million users, enhancing the online health management experience [2]

Financial Data and Key Metrics Changes - JD Health achieved revenue of RMB 35.3 billion in H1 2025, representing a year-over-year increase of 24.5% [19] - The gross profit margin increased to 25.5%, up 1.6 basis points year-over-year, reflecting improved supply chain efficiency [27] - Non-IFRS net profit rose by 35% year-over-year to RMB 6.36 billion, with a margin of 10.1%, an increase of 80 basis points [31] Business Line Data and Key Metrics Changes - Direct sales revenue increased by 22.7% year-over-year to RMB 29.3 billion, accounting for 83.1% of total revenue [20] - Service revenue reached RMB 6 billion, growing 34.4% year-over-year and representing 16.9% of total revenue [22] - The number of merchants on the online marketplace exceeded 115,000, an increase of over 15,000 since December 31, 2024 [23] Market Data and Key Metrics Changes - The online medical insurance payment services reached nearly 200 million people nationwide [24] - Instant delivery service now connects over 200,000 pharmacies across China [24] - The annual active user count reached 200 million, with a net addition of approximately 20 million compared to the previous year [20] Company Strategy and Development Direction - The company aims to enhance supply chain management and improve accessibility to pharmaceutical and healthcare products [16] - JD Health is focusing on integrating online and offline services to create a comprehensive healthcare ecosystem [17] - The strategy includes leveraging AI technologies to optimize healthcare services and improve user experience [40] Management's Comments on Operating Environment and Future Outlook - Management highlighted the positive trends in health consumption and the expanding market size driven by supportive policies [36] - The company plans to continue promoting technological innovation and enhancing user experience through AI applications [40] - Future strategies will focus on personalized health services and expanding the healthcare service ecosystem [17] Other Important Information - The company launched over 30 new products in H1 2025, including treatments for various health conditions [10] - JD Health has established five core specialty areas in healthcare services, including dermatology and mental health [26] - The company is committed to advancing the Health China 2030 initiative through partnerships and innovative service models [17] Q&A Session Summary Question: What are the middle and long-term strategies of the company? - Management emphasized the importance of adapting to health consumption changes and leveraging AI to meet user needs [36][38] Question: Can you elaborate on the AI strategy? - The company is focused on deploying AI across its services to enhance efficiency and user experience, with significant user engagement reported [42][44] Question: What is the outlook for new business formation in the second half of the year? - Management indicated plans to accelerate the rollout of next-generation pharmacies and enhance synergies between existing and new services [46][48] Question: What developments are there in medical insurance payment services? - The company aims to enhance online matching with medical insurance services and explore new healthcare service scenarios [50][52]

Financial Data and Key Metrics Changes - JD Health achieved revenue of RMB 35.3 billion, up 24.5% year over year [19] - Direct sales revenue increased to RMB 29.3 billion, constituting 83.1% of total revenue, a year-over-year increase of 22.7% [20] - Service revenue reached RMB 6 billion, representing a growth of 34.4% year over year, accounting for 16.9% of total revenue [22] - Gross profit margin increased to 25.5%, up 1.6 basis points year over year [27] - Non-IFRS net profit increased by 35% year over year to RMB 6.36 billion, with a margin of 10.1%, rising 80 basis points year over year [31] Business Line Data and Key Metrics Changes - Over 30 new pharmaceutical products were launched in the first half of the year, including treatments for various health issues [10][21] - Instant delivery service now connects over 200,000 pharmacies nationwide [24] - The number of merchants on the marketplace exceeded 115,000, an increase of over 15,000 since December 31, 2024 [23] Market Data and Key Metrics Changes - Annual active users reached 200 million, with a net addition of approximately 20 million compared to June 30, 2024 [20] - The total sales of China's health care service market is projected to reach RMB 15 trillion by 2030 [7] Company Strategy and Development Direction - The company aims to strengthen its integrated online and offline medical service ecosystem and promote technological innovation [16] - Focus on enhancing supply chain management and improving accessibility of health care products and services [16][17] - Commitment to AI application in health care to improve service efficiency and user experience [15][40] Management Comments on Operating Environment and Future Outlook - Management highlighted the positive trends in health consumption and the expansion of the market size due to supportive policies [36] - The company plans to continue leveraging AI technologies to refine health care services and improve user experience [40][44] Other Important Information - The company has established five core specialty areas in health care services, including dermatology and mental health [26] - JD Health's online hospital has launched over 500 intelligent agents, making it one of the largest online medical platforms in the industry [15] Q&A Session Summary Question: What are the middle and long-term strategies? - Management emphasized the expansion of the health care market and the importance of personalized health services [36][37] Question: Can you share more about the AI strategy? - The company is focused on deploying AI across its services to improve efficiency and user experience [41][42][44] Question: What is the status of new business formation, especially in the second half of the year? - The company is accelerating the rollout of next-generation pharmacies and enhancing user experience through omnichannel supply chain integration [45][46][48] Question: What are the developments in medical insurance payment? - The company aims to enhance online matching purchase with medical insurance services and explore new health care service scenarios [50][52]

Core Insights - JD Health reported a total revenue of 35.3 billion yuan for the first half of 2025, representing a year-on-year growth of 24.5%, with a Non-IFRS net profit of 3.57 billion yuan, up 35% [1] - The company has surpassed 200 million annual active users and has over 150,000 third-party merchants on its platform as of June 30, 2025 [1] - JD Health is focusing on enhancing its supply chain capabilities and integrating online and offline services to meet diverse health needs [1][5] Group 1: Financial Performance - Total revenue for the first half of 2025 reached 35.3 billion yuan, a 24.5% increase year-on-year [1] - Non-IFRS net profit was 3.57 billion yuan, reflecting a 35% growth compared to the previous year [1] Group 2: User Engagement and Market Position - The number of annual active users exceeded 200 million, indicating strong user engagement [1] - The platform has over 150,000 third-party merchants, enhancing its market presence [1][3] Group 3: Supply Chain and Product Offerings - JD Health is strengthening its supply chain through collaborations with leading pharmaceutical companies and health product suppliers [3] - The company launched over 30 innovative drugs online, reinforcing its position as the first stop for new specialty drugs [3] Group 4: Service Integration and User Experience - JD Health is enhancing its "medical, testing, diagnosis, and medication" service loop to cater to personalized health needs [5] - The average daily consultation volume at JD Internet Hospital exceeded 500,000, showcasing its service capacity [5] Group 5: AI Integration in Healthcare - The company is advancing AI applications in healthcare, with over 50 million users served by its AI products [6] - JD Health has launched the "JD Zuo Yi" AI product for hospitals, improving patient service processes [6] Group 6: Social Responsibility Initiatives - JD Health has engaged in various public welfare projects, providing support to over 31,000 rare disease patients [8] - The company donated over 170,000 medical care products to support earthquake relief efforts in Tibet [8] Group 7: Future Outlook - JD Health aims to enhance its supply chain and expand its healthcare service offerings while promoting AI applications for smarter healthcare solutions [8]

央广网北京8月14日消息（记者 马文静）8月14日，京东健康发布2025年中期业绩公告。2025年上 半年，京东健康总收入为人民币353亿元，同比增长24.5%；非国际财务报告准则指标下（Non-IFRS） 净利润达35.7亿元，同比增长35%。截至2025年6月30日，京东健康过去12个月的年度活跃用户数量突 破2亿；第三方合作商家数量显著增长，超过15万家，同比接近翻倍。 ...

新浪科技讯 8月14日晚间消息，京东健康发布2025年中期业绩公告。2025年上半年，京东健康总收入为 人民币353亿元，同比增长24.5%；非国际财务报告准则指标下（Non-IFRS）净利润达35.7亿元，同比增 长35%。 责任编辑：何俊熹 截至2025年6月30日，京东健康过去12个月的年度活跃用户数量突破2亿，第三方合作商家数量显著增 长，超过15万家，同比接近翻倍。 ...

智通财经APP获悉，8月14日，京东健康(06618)发布2025年中期业绩公告。2025年上半年，京东健康总 收入为人民币353亿元，同比增长24.5%；非国际财务报告准则指标下（Non-IFRS）净利润达35.7亿元， 同比增长35%。收入和净利润超出市场预期，显示出京东健康的长期价值持续释放。 2025年上半年，京东健康持续强化供应链能力，加快提升健康商品和服务供给质量、优化用户体验，从 而持续赢得更多消费者信赖。同时，京东健康还精准把握了行业增长趋势，积极推进人工智能技术驱动 服务模式创新，借助有利的行业政策支持，从而实现高质量业绩增长。 ...

8月14日，京东健康(06618)发布2025年中期业绩公告。2025年上半年，京东健康总收入为人民币353亿 元，同比增长24.5%；非国际财务报告准则指标下(Non-IFRS)净利润达35.7亿元，同比增长35%。收入和 净利润超出市场预期，显示出京东健康的长期价值持续释放。 2025年上半年，京东健康持续强化供应链能力，加快提升健康商品和服务供给质量、优化用户体验，从 而持续赢得更多消费者信赖。同时，京东健康还精准把握了行业增长趋势，积极推进人工智能技术驱动 服务模式创新，借助有利的行业政策支持，从而实现高质量业绩增长。 ...